PerkinElmer partners with Public Health Wales (PHW) to achieve the Welsh Government’s “Test, Trace, Protect” strategy by providing advanced extraction equipment and testing kits that meet the UK’s ongoing requirements.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
With the new EURORealTime SARS-CoV-2 assay, PerkinElmer expands its COVID-19 comprehensive testing portfolio to three FDA EUA solutions.
PerkinElmer has announced the addition of the DELFIA Xpress sFlt-1 kit to its CE-IVD pre-eclampsia product offering to aid in diagnosis in the second and third trimesters of pregnancy.
eXXpedition the all-female microplastics research vessel has returned to dry land due to COVID-19 but continues gaining scientific insights using our FT-IR technology.
PerkinElmer LactoScope FT-B instrument offers rapid and accurate component testing and adulterant screening for dairy products. This instrument can be paired with other PerkinElmer platforms to achieve exhaustive performance.
Amidst COVID-19, PerkinElmer is ready to support our global customers with a wide range of solutions, including detection, workflow and research.
EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits are helping Beaumont Health as part of its research study demystify COVID-19 as the research expands to wider patient groups.
EUROIMMUN provides LabCorp with dried blood spot antibody tests to screen employers as their return-to-work plans.
PerkinElmer Solus One Salmonella, an assay that offers solutions to analyze select foods and delivers results within one day, obtained OMA from AOAC INTERNATIONAL, which is considered the highest level of AOAC certification.
After CE marked in Europe, PerkinElmer’s Anti-SARS-CoV-2 ELISA serological test receives Emergency Use Authorization (EUA) from the FDA.
PerkinElmer’s MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits offer same-day testing for all five targeted antibiotic residues in farmed shrimp with high accuracy.
Stefan Tordenmalm, Market Manager of Processed Food at PerkinElmer, shares his thoughts about the adulteration of olive oil, which is at high risk for food fraud. To ensure its quality, rapid testing techniques like infrared (IR) and UV-visible spectroscopy (UV-Vis) are crucial in protecting consumers./p>
PerkinElmer’s record for positive social and environmental impact is recognized in story on company’s efforts to expand COVID-19 testing in Texas.
Tailored for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, PerkinElmer’s new analysis and automation solutions are designed to help streamline workflows, sharpen insights and meet regulations.
To answer the need for wider COVID-19 testing in the US, EUROIMMUN, a PerkinElmer company, collaborates with Quest Diagnostics to detect immunoglobulin class G (IgG) antibodies. Quest is expected to boost testing to 150,000 a day by early May.
PerkinElmer EUROLabWorkstations and EUROIMMUN Anti-SARS-CoV-2 ELISA testing kits designed to help Beaumont Health gain knowledge about disease transmission and whether COVID-19 antibodies offer protection after infection.
PerkinElmer’s instruments contribute to an antibody study at Beaumont Health, which could potentially identify those with immunity against COVID-19.
Alan Fletcher, vice president and GM, life sciences, shares insights about leveraging the potential of existing drugs to combat COVID-19.
As part of the donation from researchers at Augusta University and Georgia Tech, PerkinElmer’s products help with COVID-19 testing at the GEM lab of Medical College of Georgia.
PerkinElmer’s RT-PCR test assists in screening for COVID-19 at the Clinical and Translational Research Center, University at Buffalo. This effort helps combat COVID-19 in Erie County, NY.
PerkinElmer’s automated lab solutions support Rutgers' RUCDR Infinite Biologics, handling 10,000 nucleic acid extractions per day.
To support the diagnostics of COVID-19, the Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer company, is now CE marked in Europe.
PerkinElmer receives Emergency Use Authorization (EUA) from the FDA for the PT-PCR test for detection of COVID-19.
Dr. Stan Naides, the Director of Scientific Affairs at EUROIMMUN, a PerkinElmer company, shares his perspective on COVID-19, its progression and impact on laboratories and their personnel.
In this interview, Petra Furu, the General Manager of Reproductive Health at PerkinElmer, talks about the recently approved DMD screening kit and the promise of non-invasive testings.
Statistics show that women in China are more likely to be in senior leadership roles than many other Asian countries. Here Ms. Ye (Nicky) Xu, General Manager of Diagnostics at PerkinElmer Greater China shares her journey and some career, business and personal growth tips to help inspire the world’s women in science and healthcare.
PerkinElmer’s VICTOR EnLite Instrument and EnLite Neonatal TREC Kit will be available as part of a Severe Combined Immunodeficiency (SCID) evaluation program in collaboration with Public Health England.
When added with LPC 500™ Liquid Particle Counter, PerkinElmer’s Avio® 500 ICP-OES can analyze oils or lubricants for both wear metals and particles in one run. This costs less than 1 mL of sample and takes 45 seconds to provide accurate and stable results.
PerkinElmer launches top technologies at the Society for Laboratory Automation and Screening (SLAS) in San Diego. Highlighted products include JANUS® G3 Blood iQ™ Workstation, Sciclone® G3 NGSx HT Workstation as well as Opera Phenix® Plus High Content Screening System.
To ensure the safety of medicines, PerkinElmer offers pharma companies a comprehensive solution to detect N-nitrosodimethylamine (NDMA) impurity in ranitidine.
PerkinElmer’s liquid handling workstations facilitate sample tracking by incorporating automated barcode scanning into every step of sample processing.
Lead scientist of the eXXpedition research boat Dr. Winnie Courtene-Jones shares how the portable and powerful Spectrum Two FT/IR Spectrometer is being used on board to test for microplastics in our oceans.
As an AI-driven technology solution provider, PerkinElmer is enhancing researchers’ ability to analyze massive amounts of data in a timely fashion.
Together with PerkinElmer, New York State has screened the first infant for Duchenne as part Parent Project Muscular Dystrophy’s (PPMD's) Newborn Screening Pilot.
Cannabis and hemp labs need high quality, end-to-end testing and analysis solutions to keep up with growing demand and regulations. PerkinElmer is teaming up with Emerald Scientific to help.
With PerkinElmer’s spectrometer on board, the all-women research voyage is on the mission of identifying and documenting microplastics during the sails.
Duchenne Muscular Dystrophy is a rare genetic disorder and the most prevalent type of muscular dystrophy. The FDA has approved PerkinElmer’s GSP® Neonatal Creatine Kinase-MM (CK-MM) kit for DMD screening.
ESPGHAN recently updated guidelines for the diagnosis of Celiac disease, which are expected to be more widespread and easy for both patients and gastroenterologists.
Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.
AI and machine learning can help pharmas repurpose failed clinical trial data to drive new breakthroughs and treatments. David Wang, Masha Hoffey and Dr. Simone Sharma discuss key considerations and best practices.
PerkinElmer's new MuviCyte live-cell imaging system helps researcher study cell behavior and function in new ways. Karin Boettcher weighs in on the importance of controlling environmental parameters with advanced innovation.
PerkinElmer offers high-throughput platforms for electrophoresis-based biomolecule separation, sizing, and quantitation.
Mycotoxin testing for grains is a key step in securing global food safety. PerkinElmer’s Mark McBeath discusses best practices and innovative solutions for analysis from strips to LC-MS/MS.
PerkinElmer Genomics will begin processing about 2,500 samples with the Vanadis non-invasive prenatal testing (NIPT) system in Pittsburgh and Kuala Lumpur.
In this article PerkinElmer’s Toby Astill and Aaron Hineman weigh in on the use of ICP-MS to tackle heavy metals testing in cannabis.
Rice is a mega-staple for global consumers and testing for rice quality is key. The newPaddyCheck testing platform speeds sample throughput, increases accuracy and allows for grain testing at the paddy stage whether in-field or in a lab.
PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment.
PerkinElmer is exploring the use of deep learning methods to improve analysis of image data from high content screening—in some cases, solving problems that conventional algorithms can’t.
Food safety is paramount. In this byline, PerkinElmer’s Greg Sears discusses advances in testing and analysis for everything from heavy metals, pesticides and mycotoxins, to foodborne pathogens and antibiotics.
A new clinical study further validates PerkinElmer’s Vanadis non-invasive prenatal testing (NIPT) system, which uses fully-automated imaging instead of DNA sequencing or PCR amplification.
Dr. Madhuri Hegde of PerkinElmer Genomics talks about the critical role that genetic counseling plays in consumer-initiated DNA testing today.
In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.
To battle food fraud, PerkinElmer’s Greg Sears and Stefan Tordenmalm explain how robust analytical and informatics solutions can detect and analyze adulterants throughout the supply chain.
Beachcombing in Spain drew PerkinElmer’s Ian Robertson into not only his main field of research but an endeavor that fuels debate on microplastics in bottled water.
Linh Hoang, PerkinElmer’s vice president of Reproductive Health, spoke with Bloomberg about molecular testing options available right now for screening newborns with SMA (spinal muscular atrophy).
Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.
In this article, Dr. Marc Pollmann, EUROIMMUN biologist, outlines the factors that play into accurate identification, diagnosis and treatment of tickborne illnesses like Lyme disease.
PerkinElmer and FDNA have partnered to offer genomic services paired with next-generation phenotyping technologies. The new service combines PerkinElmer Genomics' Ordered Data Interpretation Network (ODIN) software platform with FDNA's Face2Gene facial analysis technology.
Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.
Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.
PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.
Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.
PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.
PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.
As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.
PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.